1650 PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL-DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

1650 PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL-DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG

Published:2011-04 Issue:4S Volume:185 Page:
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Morales Alvaro¹,Herr Harry²,Kamat Ashish³,Steinberg Gary⁴,Given Robert⁵,Lihou Christine⁶,Cohen Zvi⁷

Affiliation:

1. Kingston, Canada

2. New York, NY

3. Houston, TX

4. Chicago, IL

5. Norfolk, VA

6. Chadds Ford, PA

7. Belleville, Canada

Funder

Bioniche Life Sciences Inc

Endo Pharmaceuticals Inc

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes study;Urologic Oncology: Seminars and Original Investigations;2015-03

2. Avances en uro-oncología «Oncoforum»: lo mejor de 2011;Actas Urológicas Españolas;2012-10

3. Advances in uro-oncology «Oncoforum»: The best of 2011;Actas Urológicas Españolas (English Edition);2012-10

4. Response to Lammers and Witjes article: new developments in intravesical therapy for non-muscle-invasive bladder cancer;Expert Review of Anticancer Therapy;2011-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP